DE69523864T2 - PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE - Google Patents
PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATEInfo
- Publication number
- DE69523864T2 DE69523864T2 DE69523864T DE69523864T DE69523864T2 DE 69523864 T2 DE69523864 T2 DE 69523864T2 DE 69523864 T DE69523864 T DE 69523864T DE 69523864 T DE69523864 T DE 69523864T DE 69523864 T2 DE69523864 T2 DE 69523864T2
- Authority
- DE
- Germany
- Prior art keywords
- halogen
- alkyl
- phenyl
- substituted
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13863594 | 1994-06-21 | ||
JP5399795 | 1995-03-14 | ||
PCT/JP1995/001104 WO1995035298A1 (fr) | 1994-06-21 | 1995-06-05 | DERIVE DE PYRAZOLO[1,5-a]PYRIMIDINE |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69523864D1 DE69523864D1 (de) | 2001-12-20 |
DE69523864T2 true DE69523864T2 (de) | 2002-06-13 |
Family
ID=26394734
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69523864T Expired - Fee Related DE69523864T2 (de) | 1994-06-21 | 1995-06-05 | PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE |
Country Status (13)
Country | Link |
---|---|
US (1) | US5707997A (de) |
EP (1) | EP0714898B1 (de) |
KR (1) | KR100315837B1 (de) |
CN (1) | CN1046730C (de) |
AT (1) | ATE208776T1 (de) |
AU (1) | AU680370B2 (de) |
CA (1) | CA2169719C (de) |
DE (1) | DE69523864T2 (de) |
DK (1) | DK0714898T3 (de) |
ES (1) | ES2164153T3 (de) |
PT (1) | PT714898E (de) |
TW (1) | TW307767B (de) |
WO (1) | WO1995035298A1 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2206080A1 (en) * | 1995-09-28 | 1997-04-03 | Otsuka Pharmaceutical Factory, Inc. | Analgesic composition_of pryazolo{1,5-a}pyrimidine derivatives |
US6664261B2 (en) | 1996-02-07 | 2003-12-16 | Neurocrine Biosciences, Inc. | Pyrazolopyrimidines as CRF receptor antagonists |
HU229024B1 (en) * | 1996-07-24 | 2013-07-29 | Bristol Myers Squibb Pharma Co | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof |
US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
US7094782B1 (en) | 1996-07-24 | 2006-08-22 | Bristol-Myers Squibb Company | Azolo triazines and pyrimidines |
US6124289A (en) * | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
WO1998041526A1 (en) * | 1997-03-14 | 1998-09-24 | Otsuka Pharmaceutical Co., Ltd. | Novel pyrimidine derivative |
EP1149835A4 (de) * | 1999-01-29 | 2002-08-21 | Sumitomo Chemical Co | Agentien zur hemmung der fettansammlung |
AU4203500A (en) | 1999-04-06 | 2000-10-23 | Du Pont Pharmaceuticals Company | Pyrazolopyrimidines as crf antagonists |
WO2000059907A2 (en) | 1999-04-06 | 2000-10-12 | Du Pont Pharmaceuticals Company | Pyrazolotriazines as crf antagonists |
US20020061897A1 (en) | 2000-03-30 | 2002-05-23 | Elliott Richard L. | Neuropeptide Y antagonists |
US6630476B2 (en) | 2000-07-07 | 2003-10-07 | Bristol-Myers Squibb Pharma Company | Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
WO2003037900A2 (en) * | 2001-11-01 | 2003-05-08 | Icagen, Inc. | Pyrazolopyrimidines |
US20040028716A1 (en) * | 2002-06-14 | 2004-02-12 | Marks Andrew R. | Use of Y-27632 as an agent to prevent restenosis after coronary artery angioplasty/stent implantation |
TWI335919B (en) | 2002-09-04 | 2011-01-11 | Schering Corp | Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7205308B2 (en) | 2002-09-04 | 2007-04-17 | Schering Corporation | Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
US8673924B2 (en) | 2002-09-04 | 2014-03-18 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
US7161003B1 (en) | 2002-09-04 | 2007-01-09 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
PT1537116E (pt) | 2002-09-04 | 2010-09-03 | Schering Corp | Pirazolopirimidinas adequadas para o tratamento de doenças cancerosas |
US7119200B2 (en) * | 2002-09-04 | 2006-10-10 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
MY137843A (en) | 2002-09-04 | 2009-03-31 | Schering Corp | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US8580782B2 (en) | 2002-09-04 | 2013-11-12 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
AR041135A1 (es) | 2002-09-04 | 2005-05-04 | Schering Corp | Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclinas |
US7078525B2 (en) | 2002-09-04 | 2006-07-18 | Schering Corporation | Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US7196078B2 (en) | 2002-09-04 | 2007-03-27 | Schering Corpoartion | Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors |
US6949895B2 (en) * | 2003-09-03 | 2005-09-27 | Axcelis Technologies, Inc. | Unipolar electrostatic quadrupole lens and switching methods for charged beam transport |
PE20051089A1 (es) * | 2004-01-22 | 2006-01-25 | Novartis Ag | Derivados de pirazolo [1,5-a] pirimidin-7-il-amina como inhibidores de quinasa de proteina |
WO2006040645A1 (en) * | 2004-10-11 | 2006-04-20 | Ranbaxy Laboratories Limited | N-(3,5-dichloropyridin-4-yl)-2,4,5-alkoxy and 2,3,4-alkoxy benzamide derivatives as pde-iv (phophodiesterase type-iv) inhibitors for the treatment of inflammatory diseases such as asthma |
GB0519957D0 (en) | 2005-09-30 | 2005-11-09 | Sb Pharmco Inc | Chemical compound |
TW200639163A (en) * | 2005-02-04 | 2006-11-16 | Genentech Inc | RAF inhibitor compounds and methods |
EP1856119A1 (de) * | 2005-03-01 | 2007-11-21 | Basf Aktiengesellschaft | 5,6-dialkyl-7-amino-azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
WO2006092428A2 (de) * | 2005-03-02 | 2006-09-08 | Basf Aktiengesellschaft | 2-substituierte 7-amino-azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
ES2349476T3 (es) * | 2005-09-09 | 2011-01-03 | Schering Corporation | Nuevos derivados de 4-ciano, 4-amino y 4-aminometilo de compuestos de pirazolo[1,5-a]piridinas, pirazolo[1,5-c]pirimidinas y 2h-indazol y derivados de 5-ciano, 5-amino y 5-aminometilo de compuestos de imidazo[1,2-a]piridinas e imidazo[1,5-a]pirazinas, como inhibidores de cinasa dependiente de ciclina. |
AR056206A1 (es) | 2005-10-06 | 2007-09-26 | Schering Corp | Pirazolpirimidinas como inhibidores de protein quinasas |
EA201300152A1 (ru) * | 2006-11-27 | 2013-07-30 | Х. Лундбекк А/С | Гетероариламидные производные |
JP2010523668A (ja) * | 2007-04-10 | 2010-07-15 | ハー・ルンドベック・アクチエゼルスカベット | P2x7拮抗薬としてのヘテロアリールアミド類似体 |
WO2010116176A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
RU2014120180A (ru) * | 2011-10-20 | 2015-11-27 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Замещенные бициклические аза-гетероциклы и аналоги в качестве модуляторов сиртуина |
BR112014009531A8 (pt) | 2011-10-20 | 2018-01-16 | Glaxosmithkline Llc | aza-heterociclos bicíclicos substituídos e análogos como moduladores de sirtuína |
AR085073A1 (es) * | 2012-01-11 | 2013-09-11 | Richmond Sa Com Ind Y Financiera Lab | Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden |
AU2014372638A1 (en) | 2013-12-23 | 2016-06-16 | Norgine B.V. | Compounds useful as CCR9 modulators |
US20170002011A1 (en) * | 2013-12-23 | 2017-01-05 | Norgine B.V. | Benzene sulfonamides as ccr9 inhibitors |
WO2015143652A1 (en) * | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF |
MA54092A (fr) | 2018-10-30 | 2021-09-08 | Kronos Bio Inc | Composés, compositions et procédés de modulation de l'activité de cdk9 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE792533A (fr) * | 1971-12-09 | 1973-06-08 | Int Chem & Nuclear Corp | Nouvelles pyrazolo (1,5a) pyrimidines et leur procede de preparation |
US3925385A (en) * | 1972-04-20 | 1975-12-09 | Icn Pharmaceuticals | 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines |
JPS6157587A (ja) * | 1984-08-29 | 1986-03-24 | Shionogi & Co Ltd | 縮合複素環誘導体および抗潰瘍剤 |
US4950585A (en) * | 1987-08-18 | 1990-08-21 | Konica Corporation | Coupler for photographic use |
JP2585462B2 (ja) * | 1989-10-25 | 1997-02-26 | 株式会社大塚製薬工場 | ピラゾロ[1,5―a]ピリミジン誘導体 |
KR100191774B1 (ko) * | 1991-04-22 | 1999-06-15 | 오스카 아끼히꼬 | 피라졸로[1,5-알파] 피리미딘 유도체 및 이것을 함유하는 항염증제 |
DK0641781T3 (da) * | 1991-09-06 | 2000-09-18 | Yoshitomi Pharmaceutical | 4-Amino(alkyl)cyclohexan-1-carboxamidforbindelser og anvendelse af disse |
US5571813A (en) * | 1993-06-10 | 1996-11-05 | Beiersdorf-Lilly Gmbh | Fused pyrimidine compounds and their use as pharmaceuticals |
-
1995
- 1995-06-05 EP EP95920260A patent/EP0714898B1/de not_active Expired - Lifetime
- 1995-06-05 WO PCT/JP1995/001104 patent/WO1995035298A1/ja active IP Right Grant
- 1995-06-05 AU AU25765/95A patent/AU680370B2/en not_active Ceased
- 1995-06-05 US US08/602,824 patent/US5707997A/en not_active Expired - Lifetime
- 1995-06-05 KR KR1019960700854A patent/KR100315837B1/ko not_active IP Right Cessation
- 1995-06-05 ES ES95920260T patent/ES2164153T3/es not_active Expired - Lifetime
- 1995-06-05 PT PT95920260T patent/PT714898E/pt unknown
- 1995-06-05 CN CN95190760A patent/CN1046730C/zh not_active Expired - Fee Related
- 1995-06-05 AT AT95920260T patent/ATE208776T1/de not_active IP Right Cessation
- 1995-06-05 DE DE69523864T patent/DE69523864T2/de not_active Expired - Fee Related
- 1995-06-05 CA CA002169719A patent/CA2169719C/en not_active Expired - Fee Related
- 1995-06-05 DK DK95920260T patent/DK0714898T3/da active
- 1995-06-16 TW TW084106201A patent/TW307767B/zh active
Also Published As
Publication number | Publication date |
---|---|
KR100315837B1 (ko) | 2002-02-28 |
EP0714898A1 (de) | 1996-06-05 |
PT714898E (pt) | 2002-04-29 |
ES2164153T3 (es) | 2002-02-16 |
CA2169719A1 (en) | 1995-12-28 |
EP0714898A4 (de) | 1997-04-02 |
ATE208776T1 (de) | 2001-11-15 |
CN1046730C (zh) | 1999-11-24 |
WO1995035298A1 (fr) | 1995-12-28 |
CA2169719C (en) | 2002-04-16 |
KR960703919A (ko) | 1996-08-31 |
DE69523864D1 (de) | 2001-12-20 |
EP0714898B1 (de) | 2001-11-14 |
TW307767B (de) | 1997-06-11 |
US5707997A (en) | 1998-01-13 |
CN1131948A (zh) | 1996-09-25 |
DK0714898T3 (da) | 2002-03-18 |
AU680370B2 (en) | 1997-07-24 |
AU2576595A (en) | 1996-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69523864D1 (de) | PYRAZOLO[1,5-a] PYRIMIDIN-DERIVATE | |
FI906204A0 (fi) | Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi | |
EP0945452A4 (de) | Zuckerderivate, geliermittel, geliermittelzubereitungen, verfahren zu ihrer herstellung und gelzubereitungen | |
EP0955293A4 (de) | Neue harnstoffderivate | |
CA2239245A1 (en) | N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same | |
PT918776E (pt) | Sintese total de acilfulvenos antitumorais | |
MY141488A (en) | Hydroximic acid derivatives, processes for their preparation, and compositions comprising them | |
ES2169220T3 (es) | Derivados de vitamina d3 con sustituyentes en la posicion 2. | |
DE60132484D1 (de) | Chinazolinderivate und -arzneimittel | |
EP0335979A4 (en) | Thienopyrimidine derivatives | |
AU5387990A (en) | Thiazole derivatives | |
PT852226E (pt) | Derivados de pirimidina | |
AU623500B2 (en) | Carboxylimino benzothiazole derivatives | |
ES2159729T3 (es) | Derivados de pirazolo(1,5-a)pirimidina. | |
ES2033523T3 (es) | Un derivado de tioformamida. | |
WO1996022286A3 (en) | Arthropodicidal oxazines and thiazines | |
EP0418655A3 (en) | Conjugated gamma-hydroxybutenolide compounds and antiulcer agents containing the same as an effective ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |